LFWD Share Price Performance
US$0.68
-3.00 (-81.52%)
92.2% undervalued intrinsic discount
US$8.67
Fair Value
Price US$0.68
AnalystConsensusTarget US$8.67
Fair ValueUS$8.67
Share PriceUS$0.68
92.2% undervalued intrinsic discount
LFWD Community Narratives
AN
Fair Value US$8.67 92.2% undervalued intrinsic discount
FDA Clearance And Expanded Payer Channels Will Drive Advanced Mobility
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
Recent LFWD News & Updates
No updates
Lifeward Ltd. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -1.76
- Gross Margin
- 33.81%
- Net Profit Margin
- -108.21%
- Debt/Equity Ratio
- 0%
Lifeward Ltd. Competitors
About LFWD
- Founded
- 2001
- Employees
- 80
- CEO
- WebsiteView website
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals’ post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024. Lifeward Ltd. was incorporated in 2001 and is based in Yokneam Illit, Israel.
Israeli Market Performance
- 7 Days: -3.9%
- 3 Months: 11.8%
- 1 Year: 56.1%
- Year to Date: 23.8%
Over the last 7 days, the market has dropped 3.9%, driven by pullbacks in every sector, especially the Financials sector. In contrast to the last week, the market is actually up 56% over the past year. Looking forward, earnings are forecast to grow by 18% annually. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading